Background: Congenital hypothyroidism (CH) caused by defects in the development of thyroid gland, which may be genetic or genetic defects in the synthesis of and secretion of thyroxine. Other causes include defect in secretion of and action of thyrotropin (TSH) and action of thyrotropin releasing hormone and the action of triodothyronine. Using umbilical cord blood to test for total thyroxin has not been a popular newborn thyroid screening methodology. Concerns have been raised regarding false-negative test results and potential effects of maternal conditions and delivery on the interpretations of the results, as these may increase fetal thyroid-stimulating hormone (TSH) levels. Congenital hypothyroidism of any cause is difficult to recognize at birth or very soon thereafter, in part because it is mitigated to some extent in utero by maternal-foetal transfer of T4. Materials and methods: This is a Prospective, Observational and Cross-sectional study was conducted in the Department of Pediatrics, Arundathi Institute of Medical Sciences over a period of 1 year. All term neonates born to mothers and delivered during study period were included. Mothers’ clinical details T4 regarding thyroid status, hormonal therapy, weight, BMI, and other chronic medical illnesses were recorded. At the birth – basic clinical details of the baby especially related to hypothyroidism features like birth weight, tone, cry, Anterior Fontanelle size, congenital abnormality, feeding difficulty, vomiting, not passing stool/ abdominal distension, anemia, jaundice etc. were noted and entered on patient proforma. Blood sample from umbilical cord was collected in sterile container drawn from placental side of the umbilical cord at the time of birth of the baby. Result: In table 1, male were 51 (56.66%) and female were 39 (43.4%). Male-female ratio was 1.15:1. In our study, least were above 40 weeks and maximum were belonging in the week of 37+1 to 38. The birth weights ranged between 2.5 and 4.5 kg, with an average birth weight of 2.82 kg. Mean (standard deviation) TSH value was 7.725 (8.99) among the study group. In our study depicts the TSH values of the entire cohort. TSH values ranged between 1.2 and 100 mIU/ml. Conclusion: The present study, similar to other studies, suggests that TSH levels in cord blood might be a feasible alternative specimen for a congenital hypothyroidism screening program in those areas where neonatal blood is not easily attainable. An elevated cord blood TSH value has been found in substantial numbers of babies. Male sex, mode of delivery and perinatal stress factors has a significant impact on CB-TSH levels. As various other factors can influence CB-TSH, its value should be interpreted with caution.